BusinessWireSimulmedia, OptimizeRx Unlock Clinically Precise, HIPAA-Safe Targeting for TV and CTV Ads
The era of “spray-and-pray” pharmaceutical TV ads may finally be over.
In a new partnership announced today, Simulmedia, a leader in data-driven TV and streaming advertising, and OptimizeRx Corp. (Nasdaq: OPRX), a pioneer in healthcare tech, are joining forces to launch Micro-Neighborhood® Targeting (MNT) across linear, digital, and connected TV (CTV) channels.
This collaboration marks a major shift in how healthcare marketers—especially smaller and mid-sized pharma players—can activate audiences with surgical precision while remaining compliant with HIPAA and state-level privacy laws. The self-serve MNT solution enables rapid deployment of campaigns that map household-level zip-9 geographic data to clinical insights, delivering real-time, data-driven audience targeting—without compromising patient privacy.
Why This Partnership Matters
Historically, TV advertising in healthcare has been limited by blunt targeting, slow rollouts, and massive spend minimums. The Simulmedia–OptimizeRx alliance solves all three problems at once:
- Precision: MNT enables targeting based on local disease prevalence and viewing behavior.
- Speed: Campaigns can be launched quickly, with dynamic adjustments made in real-time.
- Scale: Buyers get access to over 250+ premium networks and streaming platforms in a single media buy.
“This partnership extends the reach of Micro-Neighborhood Targeting into high-impact TV environments,” said Steve Silvestro, CEO of OptimizeRx. “It offers a scalable, clinically-driven alternative—or augmentation—to traditional TV campaigns.”
The Tech Behind the Targeting
MNT isn’t just about data—it’s about actionable, compliant insight. OptimizeRx brings two patents to the table that ensure HIPAA compliance while integrating consumer and clinical data. The result: audiences that are both precisely targeted and privacy-protected.
Simulmedia’s TV+® platform complements that with predictive placement capabilities, allowing brands to reach specific patients or caregivers during critical windows in the care journey. Think beyond demographics: this is about reaching a household dealing with chronic illness right before they talk to a doctor.
“OptimizeRx gives us a powerful new lever,” said Kim Jones, SVP of Sales Strategy at Simulmedia. “We’re bridging the gap between clinical insight and high-performing media activation.”
Industry Implications: Pharma Meets Programmatic
The move comes at a time when life sciences companies are under pressure to prove ROI on their ad spend while staying within strict regulatory lanes. This partnership could reshape how healthcare brands think about full-funnel engagement, allowing them to connect awareness, education, and conversion with measurable impact.
It’s also a nod to changing expectations around personalization. Healthcare consumers—like all others—expect relevance. But delivering that in a way that’s safe, respectful, and scalable has been a long-standing challenge. MNT may be the solution advertisers and compliance officers have both been waiting for.
What’s Next?
With over 240 million adults and 2 million healthcare providers already reachable through OptimizeRx’s digital networks, the potential to integrate point-of-care messaging with high-reach TV media is significant. Expect other health tech and ad tech players to watch this move closely—and perhaps follow suit.
